NYU LANGONE HEALTH
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
A mGlu2/3 Agonist in the Treatment of PTSD
Phase 1
Terminated
- Conditions
- Post-traumatic Stress Disorder
- Interventions
- Drug: PlaceboDrug: Pomaglumetad Methionil 40mgDrug: Pomaglumetad Methionil 160mg
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 10
- Registration Number
- NCT02234687
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
Phase 1
Completed
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: IpilimumabRadiation: Radiotherapy (IMRT or 3-D CRT)
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2020-05-11
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 39
- Registration Number
- NCT02221739
- Locations
- ๐บ๐ธ
NYU Clinical Cancer Center, New York, New York, United States
๐บ๐ธNYU Langone Medical Center, Tisch Hospital, New York, New York, United States
KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer
Phase 1
Withdrawn
- Conditions
- Stomach CancerEsophageal Cancer
- Interventions
- Drug: KD019
- First Posted Date
- 2014-07-31
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT02205463
- Locations
- ๐บ๐ธ
NYU Langone Medical Center, New York, New York, United States
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
Phase 2
Withdrawn
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- Drug: PlaceboDrug: Cholecalciferol
- First Posted Date
- 2014-07-22
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT02197286
- Locations
- ๐บ๐ธ
Bellevue Hospital Center, New York, New York, United States
The Use of Paravertebral Block for Cardiac Surgery
Phase 4
Completed
- Conditions
- Mitral Valve Insufficiency
- Interventions
- Other: Paravertebral BlockOther: Placebo Comparator
- First Posted Date
- 2014-07-03
- Last Posted Date
- 2016-03-15
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 60
- Registration Number
- NCT02180893
- Locations
- ๐บ๐ธ
NYU Langone Medical Center, New York, New York, United States
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Device: PET/MRI
- First Posted Date
- 2014-07-02
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 23
- Registration Number
- NCT02180308
- Locations
- ๐บ๐ธ
NYU Langone Medical Center, New York, New York, United States
Metformin Prostate Cancer Adjuvant Trial
Phase 2
Completed
- Conditions
- Prostate Cancer RecurrentProstate Cancer
- Interventions
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2022-10-18
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 59
- Registration Number
- NCT02176161
- Locations
- ๐บ๐ธ
Winthrop University Hospital, Mineola, New York, United States
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Completed
- Conditions
- Fibromyalgia
- Interventions
- Behavioral: experience brain activity recording
- First Posted Date
- 2014-06-09
- Last Posted Date
- 2015-10-07
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 40
- Registration Number
- NCT02159300
- Locations
- ๐บ๐ธ
NYU Center for the Study & Treatment of Pain, New York, New York, United States
๐บ๐ธNYU School of Medicine; Center for Neuromagnetism, New York, New York, United States
Craniomaxillofacial Allotransplantation
Not Applicable
Terminated
- Conditions
- Facial Injuries
- Interventions
- Procedure: Craniomaxillofacial allotransplantation
- First Posted Date
- 2014-06-09
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 4
- Registration Number
- NCT02158793
- Locations
- ๐บ๐ธ
NYU Langone Medical Center, New York, New York, United States
Anti-platelet Effects of Colchicine in Healthy Volunteers
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 10
- Registration Number
- NCT02140372
- Locations
- ๐บ๐ธ
New York University School of Medicine, New York, New York, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath